Source: Annual Congress 2002 - Drug resistance in different areas
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. H. Alenova, G. B. Rakishev, A. T. Ismailova, D. S. Dilmagambetov (Almaty, Kazakhstan). Macroorganism and microorganism mutual influence under MDR-TB conditions. Eur Respir J 2002; 20: Suppl. 38, 2558

Member's Comments

No comment yet.

Related content which might interest you: From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 The influence of social and economic factors on incidence of tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005 The influence of climatic and geographical conditions on TB incidence Source: Eur Respir J 2002; 20: Suppl. 38, 161s Year: 2002 Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J 2013; 42: 1291-1301 Year: 2013 Can TB patients really perceive their health conditions Source: Eur Respir J 2005; 26: Suppl. 49, 423s Year: 2005 Population of bacteria in treatment of patients with tuberculosis by DOTS method Source: Eur Respir J 2001; 18: Suppl. 33, 175s Year: 2001 The problem of multi-drug resistant (MDR)-TB Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 The impact of drug resistance on TB control and elimination Source: International Congress 2014 – New diagnostics and better treatments for multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) Year: 2014 The effect of tobacco smoking on drug sensitivity and microbiological characteristics of Mycobacterium tuberculosis (MTB): clinical and experimental study Source: Eur Respir J 2003; 22: Suppl. 45, 158s Year: 2003 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Treatment‘s side effects in MDR tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005